Hong Yang is an experienced research scientist with a strong background in functional nano-biomaterials and respiratory diseases. She earned her B.S. in chemical engineering from Harbin Engineering University (1997–2001), followed by an M.S. in applied chemistry from Harbin Institute of Technology (2001–2003), and completed her Ph.D. in chemical engineering at the University of Waterloo (2003–2007). Her professional career includes postdoctoral positions at prestigious institutions: first at the University of Toronto's Leslie Dan Faculty of Pharmacy (2008–2009), and subsequently at the University Health Network's Latner Thoracic Surgery Research Laboratory (2009–2011). Then, she worked as a research associate in the Department of Pediatrics at the University of British Columbia and the Child & Family Research Institute (2012–2016). She held a specially appointed professor position (Eastern Scholar) at Shanghai General Hospital during 2016–2019. Since 2019, she has been working as a professor at Tianjin Medical University. Her research expertise spans nanomedicine for acute lung injury, immune modulation and immunotherapy, innate immunity, peptide-based bioactive nanodevices, high-throughput screening, and electroanalytical chemistry, demonstrating a multidisciplinary approach to biomedical research.